Mild Health Care Antibacterial Hand Soap
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
1,563 recalls, newest first
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.
Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.
Defective Delivery System: difficult to express
Lack of Assurance of Sterility: environmental monitoring report exceeds limits, therefore sterility cannot be assured.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.
Lack of sterility assurance.